Cargando…
Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire
AIMS: To evaluate the psychometric properties of a newly designed questionnaire, the 40-item Glaucoma Visual Functioning Questionnaire (GVFQ-40), in a Chinese sample to capture the visual ability of patients with glaucomatous vision impairment in five domains. METHODS: Eighty-four glaucoma suspects...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359518/ https://www.ncbi.nlm.nih.gov/pubmed/35379597 http://dx.doi.org/10.1136/bjophthalmol-2021-320985 |
_version_ | 1785075900889432064 |
---|---|
author | Huang, Haishun Lin, Junxiong Luo, Man Li, Zhidong Zhu, Yingting Han, Jiaxu Jin, Ling Li, Yiqing Zhuo, Yehong |
author_facet | Huang, Haishun Lin, Junxiong Luo, Man Li, Zhidong Zhu, Yingting Han, Jiaxu Jin, Ling Li, Yiqing Zhuo, Yehong |
author_sort | Huang, Haishun |
collection | PubMed |
description | AIMS: To evaluate the psychometric properties of a newly designed questionnaire, the 40-item Glaucoma Visual Functioning Questionnaire (GVFQ-40), in a Chinese sample to capture the visual ability of patients with glaucomatous vision impairment in five domains. METHODS: Eighty-four glaucoma suspects (controls) and 270 glaucoma patients were recruited from the Glaucoma Clinic at Zhongshan Ophthalmic Centre in this cross-sectional, observational study. All subjects completed two questionnaires during routine clinical visits: the GVFQ-40 and the validated National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25). The discriminant, criterion-related and construct validity of the GVFQ-40 were assessed. A subset of subjects completed the GVFQ-40 twice, with an interval of 7–21 days, to determine test–retest reliability. RESULTS: Domain-specific and total GVFQ-40 scores were significantly higher (worse visual ability) in glaucoma patients than in controls (all p<0.001). All pairwise subgroup comparisons were statistically significant except for the ‘mobility’ domain comparison between the mild visual field loss and control groups (p=0.189). Significant differences between these two groups were observed in only 2 of the 12 dimensions on the NEI VFQ-25. The GVFQ-40 results demonstrated strong correlations with better-eye mean deviation and Visual Field Index (glaucoma severity measures). Exploratory factor analysis tended to confirm a three-domain structure. Test–retest intraclass correlation coefficients were higher than 0.927 for domain-specific and total GVFQ-40 scores. CONCLUSIONS: The GVFQ-40 possesses good validity and reliability. It can be used to evaluate the impact of glaucomatous damage on visual ability and has potential in the evaluation of intervention efficacy. TRIAL REGISTRATION NUMBER: NCT04722861. |
format | Online Article Text |
id | pubmed-10359518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-103595182023-07-22 Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire Huang, Haishun Lin, Junxiong Luo, Man Li, Zhidong Zhu, Yingting Han, Jiaxu Jin, Ling Li, Yiqing Zhuo, Yehong Br J Ophthalmol Clinical Science AIMS: To evaluate the psychometric properties of a newly designed questionnaire, the 40-item Glaucoma Visual Functioning Questionnaire (GVFQ-40), in a Chinese sample to capture the visual ability of patients with glaucomatous vision impairment in five domains. METHODS: Eighty-four glaucoma suspects (controls) and 270 glaucoma patients were recruited from the Glaucoma Clinic at Zhongshan Ophthalmic Centre in this cross-sectional, observational study. All subjects completed two questionnaires during routine clinical visits: the GVFQ-40 and the validated National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25). The discriminant, criterion-related and construct validity of the GVFQ-40 were assessed. A subset of subjects completed the GVFQ-40 twice, with an interval of 7–21 days, to determine test–retest reliability. RESULTS: Domain-specific and total GVFQ-40 scores were significantly higher (worse visual ability) in glaucoma patients than in controls (all p<0.001). All pairwise subgroup comparisons were statistically significant except for the ‘mobility’ domain comparison between the mild visual field loss and control groups (p=0.189). Significant differences between these two groups were observed in only 2 of the 12 dimensions on the NEI VFQ-25. The GVFQ-40 results demonstrated strong correlations with better-eye mean deviation and Visual Field Index (glaucoma severity measures). Exploratory factor analysis tended to confirm a three-domain structure. Test–retest intraclass correlation coefficients were higher than 0.927 for domain-specific and total GVFQ-40 scores. CONCLUSIONS: The GVFQ-40 possesses good validity and reliability. It can be used to evaluate the impact of glaucomatous damage on visual ability and has potential in the evaluation of intervention efficacy. TRIAL REGISTRATION NUMBER: NCT04722861. BMJ Publishing Group 2023-08 2022-04-04 /pmc/articles/PMC10359518/ /pubmed/35379597 http://dx.doi.org/10.1136/bjophthalmol-2021-320985 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Clinical Science Huang, Haishun Lin, Junxiong Luo, Man Li, Zhidong Zhu, Yingting Han, Jiaxu Jin, Ling Li, Yiqing Zhuo, Yehong Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire |
title | Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire |
title_full | Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire |
title_fullStr | Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire |
title_full_unstemmed | Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire |
title_short | Development and validation of the 40-item Glaucoma Visual Functioning Questionnaire |
title_sort | development and validation of the 40-item glaucoma visual functioning questionnaire |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359518/ https://www.ncbi.nlm.nih.gov/pubmed/35379597 http://dx.doi.org/10.1136/bjophthalmol-2021-320985 |
work_keys_str_mv | AT huanghaishun developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire AT linjunxiong developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire AT luoman developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire AT lizhidong developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire AT zhuyingting developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire AT hanjiaxu developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire AT jinling developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire AT liyiqing developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire AT zhuoyehong developmentandvalidationofthe40itemglaucomavisualfunctioningquestionnaire |